Clinical Trial Update: Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating risedronate for low bone mineral density in Crohn's disease has completed, sponsored by the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: University of Alberta | Conditions: Crohn's Disease, Low Bone Mineral Density | Phase 4 | Status: COMPLETED